R. Brian Mitchell - Concepedia

Concepedia

Author

R. Brian Mitchell

Center for Cancer and Blood Disorders

Also Known As

R B Mitchell, R Brian Mitchell, R Mitchell, R. Brian Mitchell, R. Mitchell, R.B. Mitchell, R.Brian Mitchell, Reed Brian Mitchell

28

Publications

1.8K

Citations

13

H-Index

28

Concepts

All Affiliations

Center for Cancer and Blood Disorders Virginia Cancer Institute Tennessee Oncology University of Chicago Medical Center University of Chicago

RB

About

R. Brian Mitchell is an author at Center for Cancer and Blood Disorders specializing in medicine, tumor biology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	634
2	Cell Biology	3	3	369
3	Biochemistry	2	2	142
4	Health Sciences	1	1	37
5	Natural Sciences	1	1	47

R. Brian Mitchell

×

13

Publications

1.8K

Citations

12

H-Index

	Year	Citations
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants Martee L. Hensley, Karen L. Hagerty, Tarun Kewalramani, Journal of Clinical Oncology	2008	535
American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy Protectants Martee L. Hensley, LynnM. Schuchter, Celeste Lindley, Journal of Clinical Oncology	1999	334
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. M. Eileen Dolan, R. Brian Mitchell, Christine Mummert, PubMed O6-benzylguanine AnaloguesChemoprevention StrategyGliomaTumor BiologyCytotoxic Effects	1991	228
Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non–Small-Cell Lung Cancer David R. Spigel, Howard A. Burris, F. Anthony Greco, Journal of Clinical Oncology	2011	159
Syndrome of Idiopathic Hyperammonemia after High-Dose Chemotherapy: Review of Nine Cases R. Brian Mitchell, John E. Wagner, Judith E. Karp, The American Journal of Medicine HematologyPathologyIdiopathic HyperammonemiaHigh-dose ChemotherapyMedicine	1988	111
Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. R. Brian Mitchell, R C Moschel, M E Dolan PubMed Tumor BiologyOncologyChemoprevention StrategyGliomaHuman Tumor Xenografts	1992	104
Modulation of Mammalian <i>O</i><sup>6</sup>-Alkylguanine-DNA Alkyltransferase in vivo by <i>O</i><sup>6</sup>-Benzylguanine and its Effect on the Sensitivity of a Human Glioma Tumor to l-(2-chloroethyl)-3-(4-methylcyclohexyl)-l-nitrosourea M. Eileen Dolan, R. Brian Mitchell, Robert C. Moschel, Cancer Communications XenotransplantationGliomaBiochemistryMedicineTumor Growth	1990	95
Immunoendocrine Interactions During Chronic Cysticercosis Determine Male Mouse Feminization: Role of IL-6 Jorge Morales‐Montor, Saeeda Baig, R. Brian Mitchell, The Journal of Immunology	2001	59
Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea R. Brian Mitchell, M. Eileen Dolan Cancer Chemotherapy and Pharmacology Medicinal ChemistryHuman Tumor CellsBiochemistryOncogenic AgentMedicine	1993	47
Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin. Robert Hunter, Nelda G. Mold, R. Brian Mitchell, Proceedings of the National Academy of Sciences Antithymocyte GlobulinLymphocyte DevelopmentImmunologyBlood CellPathology	1985	37

Page 1